{"id":9393,"date":"2023-02-14T05:04:00","date_gmt":"2023-02-14T10:04:00","guid":{"rendered":"https:\/\/www.jacksonimmuno.com\/secondary-antibody-resource\/?p=9393"},"modified":"2026-01-29T05:52:24","modified_gmt":"2026-01-29T10:52:24","slug":"elisa-guide-part-1","status":"publish","type":"post","link":"https:\/\/www.jacksonimmuno.com\/secondary-antibody-resource\/immuno-techniques\/elisa-guide-part-1\/","title":{"rendered":"ELISA Guide; Part 1: Introduction to ELISA, Formats and Signal Amplification"},"content":{"rendered":"\n\n\n\t<div class=\"dkpdf-button-container\" style=\" text-align:right \">\n\n\t\t<a class=\"dkpdf-button\" href=\"\/secondary-antibody-resource\/wp-json\/wp\/v2\/posts\/9393?pdf=9393\" target=\"_blank\"><span class=\"dkpdf-button-icon\"><i class=\"fa fa-file-pdf-o\"><\/i><\/span> Download PDF<\/a>\n\n\t<\/div>\n\n\n\n\n\n<style>.entry p, .entry ol{font-size: 1rem;}.entry h3{color:#009fe3;margin-top:0}.entry h4{color:#009453;margin-top:1.5rem}.entry h5{color: #003a5c; font-size: 1.05rem;margin-top:1.5rem;}.entry figure{margin:32px auto;border:1px solid #ccc}.entry figure img{width:100%;display:block;margin:0 auto}.entry figcaption{font-size:.875rem;line-height:1.35rem;padding:10px;color:#222}.entry .blog-tbl{margin:1rem auto;caption-side:bottom}.entry .blog-tbl td,.entry .blog-tbl th{padding:10px 9px;border:1px solid #00172b;text-align:left}.entry .blog-tbl td{border-color:#003a5c}.entry .blog-tbl th{background-color:#00172b;color:#fff;border-left-color:#fff;border-right-color:#fff}.entry .blog-tbl th p{color:#fff}.entry .blog-tbl th:first-of-type{border-left-color:#00172b}.entry .blog-tbl th:last-of-type{border-right-color:#00172b}.entry .blog-tbl p{text-align:left;margin:0}.entry .box-note{border:2px solid #009453;padding:12px;margin:1rem 0}.entry .box-note p{margin:0;padding:0}.entry .styled-list{list-style-type:none}.entry .styled-list li{margin-top:1rem;line-height:1rem;font-size:1rem;}.entry .styled-list li::before{font-family:\"Font Awesome 5 Pro\";display:inline-block;content:\"\\f3c5\";-webkit-transform:rotate(-90deg);transform:rotate(-90deg);margin-left:-20px;margin-right:11px;font-size:.75rem;color:#ed7004;font-weight:600}.entry .styled-list ol li::before{display:none}.entry .styled-list li>ul li::before{font-weight:200}.entry .overview{width:-webkit-fit-content;width:-moz-fit-content;width:fit-content;padding:16px;margin:1rem auto;border:1px solid #eee}.entry .overview hr{margin-top:14px}.entry .overview-text{text-align:center;font-size:1rem;margin:0}.entry .btn-sq{color:#fff;font-size:.9rem;font-weight:600;border:2px solid rgb(237, 112, 4);padding:7px 13px;background:rgb(237, 112, 4);cursor:pointer;text-align:center;line-height:1.5rem;margin:0 auto;}.entry .btn-sq:hover{text-decoration:none;color:rgb(237, 112, 4);background:#fff;}.entry .btn-container{display:flex;width:100%;margin:1.3rem 0;}.entry .btn-container .fa-solid, .entry .btn-container .fa-duotone{margin-right:10px;}@media(max-width: 768px){.entry .btn-sq{font-size:1.05rem;}}<\/style>\n<style>.entry .small-fig{width: 260px;margin-left:auto;margin-right:auto;}.entry .styled-list li.nested-list::before {display: none;}.entry .styled-list li > ul li > ul li::before{content:\"\\f041\"}#contents h4 {margin-top: 15px;margin-bottom:14px;text-align:center;font-size:1.18rem}#contents {max-width:450px;margin-left:auto;margin-right:auto;}.entry h6{font-size:1rem;}<\/style>\n<p><script src=\"https:\/\/kit.fontawesome.com\/904923013f.js\" crossorigin=\"anonymous\"><\/script><\/p>\n<style>.wp-image-9850,.wp-image-9888{width:100%;}<\/style>\n<p><!--\n\n\n<h2>Lorem ipsum dolor sit amet, consectetur adipiscing elit. Etiam nisi nisl, faucibus vitae nunc vel, mattis tristique augue. Orci varius natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Praesent convallis arcu nulla, vel aliquet ligula congue vel. Nam in eros vestibulum, gravida mi non, suscipit mauris.<\/h2>\n\n\n--><\/p>\n<h4><img decoding=\"async\" loading=\"lazy\" class=\"aligncenter wp-image-9888 size-full\" src=\"https:\/\/www.jacksonimmuno.com\/secondary-antibody-resource\/wp-content\/uploads\/ELISA-1-1.jpg\" alt=\"\" width=\"600\" height=\"200\" srcset=\"https:\/\/www.jacksonimmuno.com\/secondary-antibody-resource\/wp-content\/uploads\/ELISA-1-1.jpg 600w, https:\/\/www.jacksonimmuno.com\/secondary-antibody-resource\/wp-content\/uploads\/ELISA-1-1-300x100.jpg 300w\" sizes=\"(max-width: 600px) 100vw, 600px\" \/><\/h4>\n<h4>Introduction to ELISA<\/h4>\n<p>Enzyme-linked immunosorbent assay (ELISA) was first described in 1971 when it was developed as a safer and more convenient alternative to radioimmunoassay. It has since become a widely used technique for detecting and, most importantly, quantifying one or more specific proteins within a complex mixture.<\/p>\n<p>The main advantages of ELISA are that it is quick and easy to perform and can be adapted to detect almost any analyte. ELISA is also incredibly sensitive, affords ample opportunities for multiplexing, and has the capacity to handle large sample numbers.<\/p>\n<p>Although several ELISA formats have evolved since the earliest experiments were performed, the most popular include direct detection of a pre-coated analyte on a plate by a primary antibody in conjunction with a labeled secondary.&nbsp; Another popular format is a sandwich assay, where the analyte is captured at the plate surface by a pre-coated primary antibody which is subsequently detected by another primary and labeled secondary pair. Irrespective of the chosen format, the success of any ELISA depends on high-quality antibodies and accessory reagents, and meticulous attention to detail during assay development and validation.<\/p>\n<p>The aim of this guide is to provide a general overview of the ELISA technique, highlighting the many ways that Jackson ImmunoResearch can support your ELISA-based studies. Also included is information about assay optimization, data analysis, and troubleshooting, to help you generate results you can trust. Whether you&#8217;re running an ELISA for the very first time, or you&#8217;re looking for ways to enhance an existing ELISA workflow, Jackson ImmunoResearch is here to help.<\/p>\n<p><span style=\"color: revert; font-size: revert; font-weight: revert;\">Covered in this section<\/span><\/p>\n<div id=\"contents-container\">\n<div id=\"contents\">\n<div id=\"contents-inner\">\n<h4>Overview<\/h4>\n<hr>\n<ul id=\"cont-list\" class=\"styled-list\">\n<li><a href=\"#elisa-formats\">ELISA Formats<\/a>\n<ul class=\"styled-list\">\n<li><a href=\"#elisa-direct\">Direct ELISA<\/a><\/li>\n<li><a href=\"#elisa-indirect\">Indirect ELISA<\/a><\/li>\n<li><a href=\"#elisa-sandwich\">Sandwich ELISA<\/a><\/li>\n<li><a href=\"#elisa-competitive\">Competitive ELISA<\/a><\/li>\n<\/ul>\n<\/li>\n<li><a href=\"#signal-amplification\">Signal Amplification<\/a><\/li>\n<\/ul>\n<\/div>\n<\/div>\n<\/div>\n<h4 id=\"elisa-formats\">ELISA Formats<\/h4>\n<p>Over the past 50 years, several different ELISA formats have been developed. These are categorized as direct, indirect, sandwich and competitive ELISA, with the chosen method largely being dictated by the aims of the study.<\/p>\n<h5 id=\"elisa-direct\">Direct ELISA<\/h5>\n<p>In a direct ELISA, the analyte is bound directly to the microplate wells and is then detected with a reporter-conjugated antibody specific to the target. This is shown in <strong>Figure 1<\/strong>.<\/p>\n<figure><img decoding=\"async\" src=\"https:\/\/www.jacksonimmuno.com\/secondary-antibody-resource\/wp-content\/uploads\/direct-elisa.png\" alt=\"Direct ELISA\"><figcaption><strong>Figure 1.<\/strong> Direct ELISA.<\/figcaption><\/figure>\n<p>A direct ELISA offers the advantage of being quick and easy to run since it involves little more than coating the microplate with the analyte, blocking, and then adding the detection antibody. However, it has only limited sensitivity as there is no amplification from a secondary antibody, meaning alternative formats are often preferred.<\/p>\n<p>One use for direct ELISA is to detect a specific protein in patient serum. This is achieved by coating the microplate wells with the serum sample, then adding the labeled detection antibody.<\/p>\n<h5 id=\"elisa-indirect\">Indirect ELISA<\/h5>\n<p>During an indirect ELISA, the analyte is bound directly to the microplate wells before being detected using an analyte-specific antibody in complex with a reporter molecule-conjugated secondary antibody. This is shown in <strong>Figure 2<\/strong>.<\/p>\n<figure><img decoding=\"async\" src=\"https:\/\/www.jacksonimmuno.com\/secondary-antibody-resource\/wp-content\/uploads\/indirect-elisa.png\" alt=\"Indirect ELISA\"><figcaption><strong>Figure 2.<\/strong> Indirect ELISA.<\/figcaption><\/figure>\n<p>The main advantage of an indirect ELISA is that it provides greater sensitivity than a direct ELISA because multiple secondary antibodies can bind the analyte-specific antibody. It is also more flexible since directly conjugated antibodies specific to the target analyte are not always available or can be expensive. Disadvantages of indirect ELISA are that it involves an extra protocol step compared to a direct ELISA and introduces the potential for cross-reactivity between secondary antibodies and the target analyte.<\/p>\n<p>Indirect ELISA is mainly used for measuring the antibody concentration in a sample, for example, to quantify <a href=\"\/technical\/products\/groups\/anti-human-secondary-antibodies\/serology\/selection\">antibody production<\/a> in response to vaccination with a recombinant form of the SARS-CoV-2 SPIKE protein, or during allergy testing to detect the presence of antibodies in serum following treatment with a potential allergen such as peanut oil.<\/p>\n<h5 id=\"elisa-sandwich\">Sandwich ELISA<\/h5>\n<p>Sandwich ELISA is the most commonly-used ELISA format, with almost unlimited utility for basic research as well as for clinical applications like disease diagnosis and health monitoring. This format uses matched antibody pairs for capture and detection. First, an analyte-specific capture antibody is bound directly to microplate wells which are subsequently blocked. The analyte-containing sample is then added, followed by a second analyte-specific primary antibody which may, or may not be labeled with a reporter enzyme. In cases where the second primary antibody is not labeled, a labeled secondary must be employed to generate an output signal.<\/p>\n<figure><img decoding=\"async\" src=\"https:\/\/www.jacksonimmuno.com\/secondary-antibody-resource\/wp-content\/uploads\/sandwich-elisa.png\" alt=\"Sandwich ELISA\"><figcaption><strong>Figure 3.<\/strong> Sandwich ELISA with indirect detection.<\/figcaption><\/figure>\n<p>Sandwich ELISA benefits from superior specificity compared to either a direct or indirect ELISA because two distinct analyte-binding antibodies (each recognizing a different antigenic epitope) are used. It may also provide greater sensitivity, and even low-abundance antigens can be detected within complex samples such as serum. These advantages of sandwich ELISA far outweigh its main drawback, namely that it involves more protocol steps than direct or indirect ELISA.<\/p>\n<p>It is important to remember that a sandwich ELISA relies on using a matched antibody pair that has been rigorously validated for the ELISA application. Not only is this critical to prevent the two antibodies competing with one another to bind the target epitope, but it also avoids the potential for inter-antibody cross-reactivity that can generate unwanted background signal by introducing non-specific binding.<\/p>\n<h5 id=\"elisa-competitive\">Competitive ELISA<\/h5>\n<p>Any of the ELISA formats just described can be converted to a competitive ELISA. In a competitive ELISA, the target analyte (either a protein or an antibody) competes with a reference for binding to a known amount of labeled antibody or protein. The higher the concentration of the target analyte, the lower the output signal. This is shown in Figure 4.<\/p>\n<figure><img decoding=\"async\" src=\"https:\/\/www.jacksonimmuno.com\/secondary-antibody-resource\/wp-content\/uploads\/competitive-elisa-high-analyte.png\" alt=\"Competitive ELISA - High Analyte\"><figcaption><strong>Figure 4a.<\/strong> Competitive ELISA High Analyte<\/figcaption><\/figure>\n<figure><img decoding=\"async\" src=\"https:\/\/www.jacksonimmuno.com\/secondary-antibody-resource\/wp-content\/uploads\/competitive-elisa-low-analyte.png\" alt=\"Competitive ELISA - Low Analyte\"><figcaption><strong>Figure 4b.<\/strong> Competitive ELISA Low Analyte<\/figcaption><\/figure>\n<p>A competitive ELISA determines the concentration of an antigen or an antibody in a sample by measuring signal interference. Essentially, the target of interest competes with a reference for binding to a known amount of a labeled binding partner, with a high target concentration yielding a low signal. This type of ELISA is the most challenging to set up, especially where the competing biomolecule must be labeled in-house.<\/p>\n<p>Competitive ELISA is typically used when only one antibody is available for the target analyte or when the target analyte is small and cannot be bound by two different antibodies simultaneously. Its main applications include testing blood taken from professional athletes for the presence of banned drugs and monitoring environmental samples such as river water for chemical contamination.<\/p>\n<h4 id=\"signal-amplification\">Signal amplification<\/h4>\n<p>In many situations, especially where the target analyte is present in samples at only low levels, it may be necessary to amplify the ELISA signal. A popular approach is to use labeled streptavidin-biotin-complex (LSAB) signal amplification, a technique that exploits the high-affinity <a href=\"https:\/\/www.jacksonimmuno.com\/technical\/products\/groups\/streptavidin\">streptavidin-biotin<\/a> interaction to add multiple detection moieties to the target analyte.<\/p>\n<p><strong>Figure 5<\/strong> shows a form of signal amplification using <a href=\"https:\/\/www.jacksonimmuno.com\/technical\/products\/conjugate-selection\/biotin\">biotinylated secondary antibodies<\/a> to bind the analyte-specific antibody after the primary antibody has reacted with the plate-bound analyte. By detecting this interaction with labeled <a href=\"https:\/\/www.jacksonimmuno.com\/technical\/products\/groups\/streptavidin\">streptavidin<\/a>, signal amplification is achieved by virtue of 1) multiple biotins being attached to each secondary antibody and 2) the tetrameric nature of streptavidin, which has four biotin-binding sites per molecule. It can clearly be seen that the number of detection moieties increases in the final complex.<\/p>\n<figure><img decoding=\"async\" src=\"https:\/\/www.jacksonimmuno.com\/secondary-antibody-resource\/wp-content\/uploads\/lsab-signal-amplification.png\" alt=\"Streptavidin-Biotin Method\"><figcaption><strong>Figure 5.<\/strong> Labeled streptavidin-biotin (LSAB) signal amplification.<\/figcaption><\/figure>\n<p>Another method is to use labeled <a href=\"https:\/\/www.jacksonimmuno.com\/technical\/products\/groups\/signal-enhancement\">anti-biotin antibodies<\/a> to detect biotinylated primaries. This is shown in Figure 6.<\/p>\n<figure class=\"small-fig\"><img decoding=\"async\" loading=\"lazy\" class=\"aligncenter wp-image-9347 size-medium\" src=\"https:\/\/www.jacksonimmuno.com\/secondary-antibody-resource\/wp-content\/uploads\/labeled-anti-biotin-signal-amplification-263x300.png\" alt=\"\" width=\"263\" height=\"300\" srcset=\"https:\/\/www.jacksonimmuno.com\/secondary-antibody-resource\/wp-content\/uploads\/labeled-anti-biotin-signal-amplification-263x300.png 263w, https:\/\/www.jacksonimmuno.com\/secondary-antibody-resource\/wp-content\/uploads\/labeled-anti-biotin-signal-amplification.png 331w\" sizes=\"(max-width: 263px) 100vw, 263px\" \/><figcaption><strong>Figure 6.<\/strong> Signal amplification using labeled anti-biotin antibodies to detect biotinylated primaries<\/figcaption><\/figure>\n<hr>\n<p><a href=\"https:\/\/www.jacksonimmuno.com\/technical\/products\/groups\/anti-his\"><img decoding=\"async\" loading=\"lazy\" class=\"aligncenter wp-image-9882 size-full\" src=\"https:\/\/www.jacksonimmuno.com\/secondary-antibody-resource\/wp-content\/uploads\/Anti-His-Advert_600pxX100-2.jpg\" alt=\"\" width=\"600\" height=\"100\" srcset=\"https:\/\/www.jacksonimmuno.com\/secondary-antibody-resource\/wp-content\/uploads\/Anti-His-Advert_600pxX100-2.jpg 600w, https:\/\/www.jacksonimmuno.com\/secondary-antibody-resource\/wp-content\/uploads\/Anti-His-Advert_600pxX100-2-300x50.jpg 300w\" sizes=\"(max-width: 600px) 100vw, 600px\" \/><\/a><\/p>\n<table class=\"table blogLinks aligncenter\">\n<thead>\n<tr>\n<th class=\"span6\">Learn more:<\/th>\n<th class=\"span6\">Do more:<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td class=\"span6\"><a href=\"\/secondary-antibody-resource\/immuno-techniques\/colorimetric-western-blotting\/\">Colorimetric western blotting<\/a><\/td>\n<td class=\"span6\"><strong><a href=\"https:\/\/www.jacksonimmuno.com\/technical\/products\/conjugate-selection\/fluorophore-selection#spectra\">Spectra Viewer<\/a><\/strong><\/td>\n<\/tr>\n<tr>\n<td class=\"span6\"><a href=\"\/secondary-antibody-resource\/immuno-techniques\/fluorescent-western-blotting\/\">Chemiluminescence western blotting<\/a><\/td>\n<td class=\"span6\"><a href=\"\/technical\/products\/groups\/signal-enhancement\">Antibodies for signal enhancement<\/a><\/td>\n<\/tr>\n<tr>\n<td class=\"span6\" colspan=\"2\"><a href=\"\/secondary-antibody-resource\/immuno-techniques\/fluorescent-western-blotting\/\">Fluorescent western blotting<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<!-- AddThis Advanced Settings generic via filter on the_content --><!-- AddThis Share Buttons generic via filter on the_content --><!-- AddThis Related Posts generic via filter on the_content -->","protected":false},"excerpt":{"rendered":"<p>Download PDF Introduction to ELISA Enzyme-linked immunosorbent assay (ELISA) was first described in 1971 when it was developed as a safer and more convenient alternative to radioimmunoassay. It has since become a widely used technique for detecting and, most importantly, quantifying one or more specific proteins within a complex mixture. The main advantages of ELISA [&hellip;]<!-- AddThis Advanced Settings generic via filter on get_the_excerpt --><!-- AddThis Share Buttons generic via filter on get_the_excerpt --><!-- AddThis Related Posts generic via filter on get_the_excerpt --><\/p>\n","protected":false},"author":14,"featured_media":9888,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"content-type":""},"categories":[3,16],"tags":[],"acf":[],"_links":{"self":[{"href":"https:\/\/www.jacksonimmuno.com\/secondary-antibody-resource\/wp-json\/wp\/v2\/posts\/9393"}],"collection":[{"href":"https:\/\/www.jacksonimmuno.com\/secondary-antibody-resource\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.jacksonimmuno.com\/secondary-antibody-resource\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.jacksonimmuno.com\/secondary-antibody-resource\/wp-json\/wp\/v2\/users\/14"}],"replies":[{"embeddable":true,"href":"https:\/\/www.jacksonimmuno.com\/secondary-antibody-resource\/wp-json\/wp\/v2\/comments?post=9393"}],"version-history":[{"count":23,"href":"https:\/\/www.jacksonimmuno.com\/secondary-antibody-resource\/wp-json\/wp\/v2\/posts\/9393\/revisions"}],"predecessor-version":[{"id":11541,"href":"https:\/\/www.jacksonimmuno.com\/secondary-antibody-resource\/wp-json\/wp\/v2\/posts\/9393\/revisions\/11541"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.jacksonimmuno.com\/secondary-antibody-resource\/wp-json\/wp\/v2\/media\/9888"}],"wp:attachment":[{"href":"https:\/\/www.jacksonimmuno.com\/secondary-antibody-resource\/wp-json\/wp\/v2\/media?parent=9393"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.jacksonimmuno.com\/secondary-antibody-resource\/wp-json\/wp\/v2\/categories?post=9393"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.jacksonimmuno.com\/secondary-antibody-resource\/wp-json\/wp\/v2\/tags?post=9393"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}